INCYTE CORP

INCY

INCYTE CORP

INCY

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-04Shares Purchased (TTM):0Shares Sold (TTM):332,451

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:192,808,107Shares Outstanding:199,343,000Institutional Ownership Pct.:96.72%

Earnings Market Reaction:

Filing Date:2026-04-28Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Commercial Physical & Biological Research

IQV MEDP CRL ABSI NRC OABI

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	3,461	3,098	2,455	1,955	1,942	1,688	1,304	987	3,346	3,213	3,227	3,131
Available For Sale Securities Debt Securities Curr…	-	-	-	-	-	-	467	462	504	443	289	292
Equity Securities Fv Ni	-	-	-	-	-	-	3	70	-	-	-	-
Debt Securities Available For Sale Excluding Accru…	555	483	475	467	467	470	-	-	-	443	-	-
Accounts Receivable Net	1,051	1,024	896	843	823	853	758	739	746	744	657	638
Inventory Net	116	101	83	83	64	59	70	101	64	63	57	36
Prepaid Expense And Other Assets Current	301	318	369	296	212	169	205	208	189	183	172	167
Assets Current	5,484	5,024	4,278	3,644	3,507	3,239	2,809	2,567	4,849	4,645	4,403	4,264
Restricted Cash Noncurrent	2	2	2	2	2	2	2	2	2	2	2	2
Long Term Investments	-	-	-	-	-	-	-	-	288	188	154	170
Equity Securities F V N I Noncurrent	55	48	22	13	17	19	28	30	-	188	-	-
Inventory Noncurrent	331	342	367	368	365	348	298	255	264	207	142	142
Property Plant And Equipment Net	720	731	799	799	765	763	773	762	720	752	733	749
Finance Lease Right Of Use Asset	27	28	28	29	30	31	25	26	26	26	25	26
Other Intangible Assets Net	110	117	119	126	108	114	120	114	118	124	129	135
Goodwill	133	133	156	156	156	156	156	156	156	156	156	156
Deferred Income Tax Assets Net	453	515	528	652	769	762	762	730	667	632	564	533
Other Assets Noncurrent	24	18	32	33	30	11	40	22	47	52	81	32
Assets	7,339	6,958	6,330	5,821	5,749	5,444	5,012	4,662	7,136	6,782	6,388	6,208
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	229	210	172	241	196	197	179	148	164	110	139	156
Employee Related Liabilities Current	125	228	168	129	103	189	151	114	89	153	125	112
Accrued Liabilities Current	1,092	1,032	948	857	1,376	1,212	1,128	1,034	1,102	936	821	811
Finance Lease Liability Current	4	5	4	4	4	4	4	4	4	3	3	3
Business Combination Contingent Consideration Liab…	39	41	46	47	42	39	40	37	37	38	37	38
Liabilities Current	1,490	1,515	1,339	1,279	1,720	1,642	1,502	1,337	1,396	1,240	1,125	1,119
Business Combination Contingent Consideration Liab…	71	80	138	160	153	154	167	157	165	174	170	179
Finance Lease Liability Noncurrent	29	30	31	32	33	34	28	29	29	29	29	29
Other Liabilities Noncurrent	127	165	171	180	176	168	145	142	151	149	133	140
Liabilities	1,716	1,790	1,679	1,650	2,082	1,997	1,841	1,665	1,741	1,592	1,457	1,468
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	5,083	4,928	4,722	4,667	4,588	4,533	4,429	4,383	5,070	5,016	4,949	4,926
Accumulated Other Comprehensive Income Loss Net Of…	22	25	15	13	-6	-13	16	-5	-6	13	23	27
Retained Earnings Accumulated Deficit	517	214	-86	-510	-915	-1,073	-1,274	-1,380	330	160	-41	-212
Stockholders Equity	5,623	5,167	4,651	4,171	3,668	3,448	3,171	2,997	5,394	5,190	4,931	4,741
Liabilities And Stockholders Equity	7,339	6,958	6,330	5,821	5,749	5,444	5,012	4,662	7,136	6,782	6,388	6,208
Debt Securities Available For Sale Amortized Cost …	-	-	-	-	-	-	464	464	506	443	291	294
Debt Securities Available For Sale Amortized Cost …	555	481	473	465	466	470	-	-	-	443	-	-
Debt Securities Available For Sale Allowance For C…	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	400	400	400	400	400	400	400	400	400	400	400	400
Common Stock Shares Issued	200	198	196	194	194	193	193	192	225	224	224	223
Shares Outstanding	200	198	196	194	194	193	193	192	225	224	224	223

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-0.59%	0.49%	19.96%	-	-	-	-	-	-	-	-	-
2025	6.32%	13.29%	12.30%	9.90%	11.82%	13.17%	11.36%	12.05%	15.89%	-4.11%	-4.12%	-3.14%
2024	10.11%	21.46%	26.55%	-5.38%	-3.02%	-2.07%	-2.55%	-6.47%	-2.27%	3.65%	-11.30%	-8.45%
2023	-10.55%	-10.73%	-8.30%	0.27%	-8.78%	-13.44%	-0.35%	16.54%	14.02%	1.15%	-6.91%	-9.40%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.68	3.32	3.20	2.85	2.04	1.97	1.87	1.92	3.47	3.75	3.91	3.81
Quick Ratio	3.40	3.04	2.86	2.55	1.88	1.83	1.69	1.69	3.29	3.55	3.71	3.63
Working Capital	3.99B	3.51B	2.94B	2.37B	1.79B	1.60B	1.31B	1.23B	3.45B	3.41B	3.28B	3.15B
Leverage & Debt
Debt to Equity	0.31	0.35	0.36	0.40	0.57	0.58	0.58	0.56	0.32	0.31	0.30	0.31
Interest Coverage TTM	689.26	623.91	653.65	483.48	69.58	26.91	-19.84	6.26	273.75	243.25	208.51	175.58
Debt Ratio	0.23	0.26	0.27	0.28	0.36	0.37	0.37	0.36	0.24	0.23	0.23	0.24
Efficiency & Turnover
Asset Turnover TTM	0.82	0.83	0.85	0.87	0.69	0.69	0.62	0.61	0.50	0.50	0.61	0.61
Per Share Metrics
Diluted EPS TTM	6.92	6.41	5.90	4.38	0.11	0.15	0.17	0.45	3.28	2.65	1.88	1.62
Free Cash Flow Per Share TTM	7.46	7.11	6.27	5.11	1.90	1.55	0.46	-0.29	3.66	2.15	2.66	3.21
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	92.47%	92.76%	92.95%	92.88%	92.65%	92.64%	91.73%	91.96%	92.00%	91.94%	93.23%	93.20%
Operating Profit Margin TTM	30.05%	29.46%	30.76%	25.80%	3.96%	1.45%	-1.49%	0.47%	21.24%	19.60%	13.95%	12.15%
Net Profit Margin TTM	26.71%	25.03%	24.69%	18.99%	0.48%	0.77%	0.92%	2.92%	23.03%	18.88%	11.78%	10.43%
Growth Metrics
Net Revenue Growth (1Y)	21.48%	21.22%	35.76%	37.83%	36.32%	34.00%	-1.76%	-5.32%	-6.71%	-6.76%	8.35%	5.81%
Net Income Growth (1Y)	6,631.44%	3,844.96%	3,559.21%	795.08%	-97.15%	-94.54%	-92.36%	-73.45%	129.81%	75.42%	-51.49%	-61.22%
EPS Growth (1Y)	6,441.29%	4,085.58%	3,502.34%	906.65%	-96.69%	-94.11%	-91.11%	-72.83%	128.25%	74.15%	-51.85%	-61.49%
Valuation Metrics
P/E TTM	13.10	14.98	13.96	15.17	551.45	438.60	391.99	135.93	17.16	23.50	30.46	37.92
P/B TTM	3.34	3.73	3.57	3.17	3.20	4.15	4.02	4.41	2.37	2.71	2.62	2.93
P/S TTM	3.50	3.75	3.45	2.88	2.66	3.37	3.59	3.98	3.95	4.44	3.59	3.96
Market Cap	18.76B	19.28B	16.59B	13.21B	11.73B	14.31B	12.73B	13.23B	12.79B	14.04B	12.94B	13.90B
Enterprise Value	15.33B	16.22B	14.17B	11.29B	9.82B	12.65B	11.46B	12.27B	9.47B	10.86B	9.75B	10.80B
Calculated Values
Free Cash Flow TTM	1.49B	1.39B	1.23B	990.40M	368.69M	321.44M	87.95M	-62.59M	820.90M	481.49M	596.15M	716.88M
Net Debt	-3.43B	-3.06B	-2.42B	-1.92B	-1.91B	-1.65B	-1.27B	-956.31M	-3.32B	-3.18B	-3.20B	-3.10B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-04Sale

Owner: Tray, Thomas

Title: Principal Accounting Officer

Shares: 2,639

Price/Share: $100.00

Value: $263,900.00

Shares Owned: 21,132

Relationship: Officer

Ownership: Direct

2026-05-26Sale

Owner: Tray, Thomas

Title: Principal Accounting Officer

Shares: 2,051

Price/Share: $97.35

Value: $199,664.85

Shares Owned: 21,132

Relationship: Officer

Ownership: Direct

2026-05-19Sale

Owner: Clancy, Paul J

Title: -

Shares: 15,000

Price/Share: $94.93

Value: $1,423,950.00

Shares Owned: 23,741

Relationship: Director

Ownership: Direct

2026-04-17Sale

Owner: Cagnoni, Pablo J

Title: President, Global Head of R&D

Shares: 18,667

Price/Share: $96.50

Value: $1,801,365.50

Shares Owned: 262,692

Relationship: Officer

Ownership: Direct

2026-03-17Sale

Owner: Cagnoni, Pablo J

Title: President, R&D

Shares: 18,667

Price/Share: $94.24

Value: $1,759,178.08

Shares Owned: 234,800

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-04	Tray, Thomas	Officer	Principal Accounting Officer	Direct	Sale	2,639	100.00	$263,900.00	21,132	4
2026-05-26	Tray, Thomas	Officer	Principal Accounting Officer	Direct	Sale	2,051	97.35	$199,664.85	21,132	4
2026-05-19	Clancy, Paul J	Director	-	Direct	Sale	15,000	94.93	$1,423,950.00	23,741	4
2026-04-17	Cagnoni, Pablo J	Officer	President, Global Head of R&D	Direct	Sale	18,667	96.50	$1,801,365.50	262,692	4
2026-03-17	Cagnoni, Pablo J	Officer	President, R&D	Direct	Sale	18,667	94.24	$1,759,178.08	234,800	4
2026-02-19	Cagnoni, Pablo J	Officer	President, R&D	Direct	Sale	18,668	100.91	$1,883,787.88	234,800	4
2026-01-07	Issa, Mohamed Khairie	Officer	EVP, Head of US Oncology	Direct	Sale	10,856	109.07	$1,184,063.92	66,132	4
2026-01-05	Stein, Steven H	Officer	EVP & Chief Medical Officer	Direct	Sale	15,634	101.70	$1,589,977.80	34,203	4
2025-12-19	Tray, Thomas	Officer	Principal Accounting Officer	Direct	Sale	2,774	100.00	$277,400.00	22,973	4
2025-12-17	Morrissey, Michael James	Officer	EVP, Head of Tech. Operations	Direct	Sale	4,323	97.26	$420,454.98	27,507	4
2025-12-11	Mayes, Patrick A	Officer	EVP & Chief Scientific Officer	Direct	Sale	255	94.94	$24,209.70	60,011	4
2025-12-02	Stein, Steven H	Officer	EVP & Chief Medical Officer	Direct	Sale	20,105	102.51	$2,060,963.55	63,129	4
2025-11-24	Tray, Thomas	Officer	Principal Accounting Officer	Direct	Sale	600	103.00	$61,800.00	23,573	4
2025-11-17	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	278	104.36	$29,012.08	26,569	4
2025-11-10	Hoppenot, Herve	Director	-	Direct	Sale	187,500	105.46	$19,773,750.00	329,646	4
2025-11-05	Stein, Steven H	Officer	EVP & Chief Medical Officer	Direct	Sale	5,233	102.20	$534,812.60	102,886	4
2025-11-04	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	598	101.36	$60,613.28	26,569	4
2025-11-03	Heeson, Lee	Officer	EVP, Head of Incyte Intl	Direct	Sale	3,074	94.02	$289,017.48	29,241	4
2025-10-15	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	277	85.13	$23,581.01	26,569	4
2025-10-03	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	3,501	85.54	$299,475.54	26,569	4
2025-09-16	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	278	83.15	$23,115.70	33,200	4
2025-09-02	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	598	84.97	$50,812.06	33,200	4
2025-08-15	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	277	86.81	$24,046.37	33,200	4
2025-08-04	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	598	75.77	$45,310.46	33,200	4
2025-07-21	Stein, Steven H	Officer	EVP & Chief Medical Officer	Direct	Sale	3,706	67.94	$251,785.64	102,886	4
2025-07-16	Flannelly, Barry P	Officer	EVP & General Manager US	Direct	Sale	1,340	68.36	$91,602.40	35,149	4
2025-07-16	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	785	68.36	$53,662.60	33,200	4
2025-07-16	Iyengar, Vijay K	Officer	EVP, GMAPPS	Direct	Sale	983	68.36	$67,197.88	40,540	4
2025-07-15	Iyengar, Vijay K	Officer	EVP, GMAPPS	Direct	Sale	1,177	69.86	$82,225.22	35,929	4
2025-07-15	Flannelly, Barry P	Officer	EVP & General Manager US	Direct	Sale	1,192	69.86	$83,273.12	37,630	4
2025-07-14	Stein, Steven H	Officer	EVP & Chief Medical Officer	Direct	Sale	14,952	68.47	$1,023,763.44	97,466	4
2025-07-03	Iyengar, Vijay K	Officer	EVP, GMAPPS	Direct	Sale	8,617	68.16	$587,334.72	37,701	4
2025-07-03	Flannelly, Barry P	Officer	EVP & General Manager US	Direct	Sale	10,903	68.15	$743,039.45	39,744	4
2025-07-02	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	599	68.61	$41,097.39	26,504	4
2025-06-03	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	1,795	68.00	$122,060.00	26,504	4
2025-06-02	Tray, Thomas	Officer	Principal Accounting Officer	Direct	Sale	651	64.88	$42,236.88	22,003	4
2025-03-14	Flannelly, Barry P	Officer	EVP & General Manager US	Direct	Sale	19,807	67.80	$1,342,914.60	33,567	4
2025-03-04	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	599	69.99	$41,924.01	25,848	4
2025-02-26	Denton, Sheila A.	Officer	EVP & General Counsel	Direct	Sale	14,069	74.07	$1,042,090.83	25,848	4
2025-01-21	Stein, Steven H	Officer	EVP & Chief Medical Officer	Direct	Sale	12,352	72.69	$897,866.88	66,967	4
2024-12-16	Tray, Thomas	Officer	Principal Accounting Officer	Direct	Sale	650	69.31	$45,051.50	23,312	4
2024-11-29	Iyengar, Vijay K	Officer	EVP, GMAPPS	Direct	Sale	6,043	75.48	$456,125.64	30,658	4
2024-11-06	Flannelly, Barry P	Officer	EVP & General Manager US	Direct	Sale	3,680	80.10	$294,768.00	58,042	4
2024-09-13	Tray, Thomas	Officer	Principal Accounting Officer	Direct	Sale	382	63.37	$24,207.34	24,443	4
2024-09-12	Dickinson, Jonathan Ellio…	Officer	EVP, General Manager, Europe	Direct	Sale	8,450	62.33	$526,688.50	36,390	4
2024-08-12	Stein, Steven H	Officer	EVP & Chief Medical Officer	Direct	Sale	11,608	60.63	$703,793.04	90,011	4
2024-07-25	Iyengar, Vijay K	Officer	EVP, GMAPPS	Direct	Sale	15,571	70.00	$1,089,970.00	36,701	4
2024-07-16	Flannelly, Barry P	Officer	EVP & General Manager US	Direct	Sale	1,306	64.19	$83,832.14	58,042	4
2024-07-09	Flannelly, Barry P	Officer	EVP & General Manager US	Direct	Sale	8,148	60.00	$488,880.00	50,534	4
2024-06-12	Flannelly, Barry P	Officer	EVP & General Manager US	Direct	Sale	19,164	60.00	$1,149,840.00	66,377	4
2024-06-06	Tray, Thomas	Officer	Principal Accounting Officer	Direct	Sale	1,093	58.91	$64,388.63	21,634	4
2024-01-03	Stein, Steven H	Officer	EVP & Chief Medical Officer	Direct	Sale	7,365	65.51	$482,481.15	90,218	4
2024-01-02	Iyengar, Vijay K	Officer	EVP, GMAPPS	Direct	Sale	657	65.00	$42,705.00	43,412	4
2023-12-13	Tray, Thomas	Officer	Principal Accounting Officer	Direct	Sale	1,067	62.37	$66,548.79	23,436	4
2023-09-01	Swain, Paula J	Officer	EVP, Human Resources	Direct	Sale	8,449	65.13	$550,283.37	77,530	4
2023-08-01	Stein, Steven H	Officer	EVP & Chief Medical Officer	Direct	Sale	21,511	63.28	$1,361,216.08	97,583	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

96.72%

Inst. Shares: 192,808,107

Shares Outstanding: 199,343,000

2025-12-31

97.00%

Inst. Shares: 189,346,853

Shares Outstanding: 195,204,000

2025-09-30

95.92%

Inst. Shares: 187,692,429

Shares Outstanding: 195,670,000

2025-06-30

95.28%

Inst. Shares: 184,836,490

Shares Outstanding: 193,995,000

2025-03-31

90.82%

Inst. Shares: 175,931,718

Shares Outstanding: 193,712,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	192,808,107	199,343,000	96.72%
2025-12-31	189,346,853	195,204,000	97.00%
2025-09-30	187,692,429	195,670,000	95.92%
2025-06-30	184,836,490	193,995,000	95.28%
2025-03-31	175,931,718	193,712,000	90.82%
2024-12-31	171,713,959	207,110,000	82.91%
2024-09-30	171,763,441	192,629,000	89.17%
2024-06-30	185,111,491	218,175,000	84.85%
2024-03-31	197,733,718	224,484,000	88.08%
2023-12-31	200,005,806	223,628,000	89.44%
2023-09-30	196,939,790	224,078,000	87.89%
2023-06-30	194,040,444	223,248,000	86.92%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

INCYTE CORP (INCY) — SEC Financial Statements & Analysis

INCYTE CORP (INCY) is a services-commercial physical & biological research company, incorporated in DE. INCYTE CORP trades on INCY: Nasdaq as: INCY. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), INCYTE CORP reported a 21.48% year-over-year revenue growth, a Gross Profit Margin of 92.47% (TTM), a Debt-to-Equity ratio of 0.31x, a Price-to-Sales (P/S) ratio of 3.50x (TTM), a Price-to-Book (P/B) ratio of 3.34 (TTM), at a market cap of $18.76B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 21.48%
Gross Profit Margin TTM: 92.47%
Debt To Equity: 0.31x
P/S TTM: 3.50x
P/B TTM: 3.34
Market Cap: $18.76B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is INCYTE CORP in?

INCYTE CORP (INCY) operates in the Services-Commercial Physical & Biological Research industry.

What is INCY's market cap?

INCYTE CORP (INCY) has a market capitalization of $18.76B as of 2026-03-31.

What is INCY's P/E ratio?

INCYTE CORP (INCY)'s trailing twelve month P/E ratio is 13.10x as of 2026-03-31.

What exchange does INCY trade on?

INCYTE CORP (INCY) trades on the INCY: Nasdaq.

Where is INCYTE CORP incorporated?

INCYTE CORP is incorporated in DE.

INCYTE CORP (INCY) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.